ReviewJournal of cardiovascular development and disease2026
Cardiometabolic Substrate Modification in Atrial Fibrillation: Obesity and Epicardial Adipose Tissue in the Era of Incretin-Based Therapies and Catheter Ablation.
Andrea Matteucci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.